Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. The Drug Enforcement Agency (DEA) currently has guidance published for those interested in petitioning for a religious exemption to the CSA. Schedule I.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Canna Law Blog

JANUARY 3, 2023

Until recently, CBD resided in a legal penumbra where hemp was still scheduled on the federal Controlled Substances Act and could not be cultivated without a permit from the Drug Enforcement Administration (“DEA”). A multitude of states now allow CBD in food and drinks for consumption by humans and animals.

CBD 75

CBD Food Clinical Trials Pets 75

Veriheal

AUGUST 31, 2020

However, social and economic barriers like racial stereotypes and lack of access to care centers have historically barred Hispanic community members from seeking medical cannabis and participating in clinical trials. Supply chains are disrupted as a result, and consumers grow fearful of buying hemp.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

JUNE 4, 2021

However, Delta 8-THC is explicitly listed on the DEA 7370 Controlled Substance list, so it’s hard to imagine the cases ending in any other way than saying Delta 8-THC should be regulated like cannabis. . . Are there states that you think they’ll let Delta 8 run and be sold alongside other rec products?

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Cannabis Law Report

MARCH 21, 2019

Although the DEA refuses to remove marijuana from the schedule 1 list, the Farm Bill is considered to be the most important victory in the history of U.S. In 2017, Kentucky approved the House Bill 333 that legalized the consumption and retail sale of CBD containing up to 0.3% You can find the list of medical conditions here.

State Laws 55

State Laws Law CBD Legalization 55

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. 32: United States DEA.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73